Biblio
Export 1129 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is T [Clear All Filters]
“TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer's Disease and in Response to Hippocampal Deafferentation in Rodents.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1547-1556, 2018.
, “Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 64, no. 1, pp. 249-267, 2018.
, “Translational Research in Alzheimer's and Prion Diseases.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1247-1259, 2018.
, “The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1241-1245, 2018.
, “The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1241-1245, 2018.
, “Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S497-S505, 2018.
, “Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S497-S505, 2018.
, “Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 765-779, 2018.
, “Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
, “Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1025-1033, 2018.
, “Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1539-1548, 2018.
, “Which Risk Factors Causally Influence Dementia? A Systematic Review of Mendelian Randomization Studies.”, J Alzheimers Dis, vol. 64, no. 1, pp. 181-193, 2018.
, “Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?”, J Alzheimers Dis, vol. 61, no. 1, pp. 47-52, 2018.
, “Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.”, J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
, “Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.”, J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
, “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
, “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
, “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
, “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
, “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
, “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
, “Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1429-1438, 2019.
, “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
, “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
,